medigraphic.com
ISSN 1561-3119 (Electronic)

2017, Number S1

<< Back Next >>

Rev Cubana Pediatr 2017; 89 (S1)

Surveillance of patients with pneumococcal disease and admitted to 'Antonio María Beguez César' Southern Teaching Pediatric Hospital

Tamayo RCM, Pajaro MM, Díaz TD, Maren GM, Maceira SS, Cunill RS

Language: Spanish
References: 20
Page: 156-165
PDF size: 237.46 Kb.


ABSTRACT

Introduction: the southern pediatric hospital is one of the sentinel sites for the surveillance of the pneumococcal disease in hospitalized children younger than 5 years, which demands information on clinical studies and supports the present research.
Objective: to describe the epidemiological, clinical and microbiological characteristics of patients younger than 5 years, who had been admitted to the southern pediatric hospital with diagnoses of invasive and non invasive diseases from October 2014 to October 2015. The percents age calculation of results was made.
Results: the sample represented 64.5 % of cases with diagnosis of pneumococcal disease; 69.8 % were males, mostly breast-fed infants (52.6 %) and pneumococcal isolates in 9.6 % of cases. Pneumonia was responsible for 85 % of patients, with pneumococcal isolates in 7.5 %; clinically severe conditions in 62 % and 3 deaths. Pneumococci were isolated in 18.1 % and in 100 % of patients with acute otitis media and rhinosinusitis, respectively. Diagnosis of bacterial meningitis was made in 2.1 % and one child died. Higher positivity was observed for pneumococcus (6.4 %) in the nasopharyngeal exudates, and the isolated serogroups in non invasive diseases were 19F, 3 and 15B; whereas 6A and 14 serotypes were found in invasive and non invasive diseases.
Conclusions: breast-fed infants and non invasive forms of pneumococcal disease predominate and pneumococcal isolates conducive to colonization were more common in the one to four year group. In contrast with the above-mentioned, the invasive pneumococcal disease caused by meningitis was absent in the period.


REFERENCES

  1. Zamorano J. Nuevas vacunas antineumocócica conjugadas: recorriendo su éxito. Medwave. 2010 Feb;10(02):e4375.

  2. Grupo de Trabajo para la Vigilancia y Evaluación de Impacto. Proyecto Neumococo. Vigilancia y Evaluación del Impacto de la Vacuna Cubana contra los Neumococos. Protocolo de Vigilancia Centinela Integrada de Base Hospitalaria [homepage en Internet]; La Habana, Abril 2014 [citado 19 de Septiembre de 2016]. Disponible en: www.finlay.edu.cu

  3. Toraño Peraza G. Serotipos de Streptococcus pneumoniae en Cuba y progresión de la resistencia a la penicilina. Rev Cubana Med Trop. 2010;62(2):157-60.

  4. OPS. Vigilancia de las neumonías y meningitis bacterianas en menores de 5 años. Guía Práctica. Publicación Científica y Técnica No. 633. Washington: OPS; Abril 2009.

  5. Valenzuela MT, Seoane M, Canals A, Pidal P, Hormazábal JC, Araya P, et al. Vigilancia de laboratorio de Streptococcus pneumoniae procedente de enfermedad invasora, Chile 2007-2012. Rev Chil Infectol. 2014 Dic;31(6):651-8.

  6. Constenla D, Gomez E, Pio de la Hoz F, O'Loughlin R, Sinha A, Valencia JE, et al. The burden of pneumococcal disease and cost-effectiveness of a pneumococcal vaccine in Latin America and the Caribbean: A review of the evidence and a preliminary economic analysis [homepage en Internet]; Washington D.C. The Albert B. Sabin Vaccine Institute, 2007 [citado 19 de Septiembre de 2016]. Disponible en: http://www.ispch.cl/sites/default/files/document1.pdf

  7. Burrell C, Booy R, Word N, Egan AM, Taverner D, Williams K, et al. Immunogenicity of a reduced dose of A/H3N2 in the 2005 southern hemisphere formulation of inactivated split influenza vaccine. Influenza and other Respiratory Viruses. 2008;2(3):93-8.

  8. Gabastou J, Agudelo CI, Brandileone MC, Castañeda E, Lemos APS, de Di FJL. Caracterización de aislamientos invasivos de S. pneumoniae, H. influenzae y N. meningitidis en América Latina y el Caribe: SIREVA II, 2000-2005. Rev Panam Salud Pública. 2008 July;24(1):1-15.

  9. Chanto G, Bolaños HM. Informe de vigilancia basada en laboratorio de Streptococcus pneumoniae y su aporte al análisis de las estrategias de vacunación en Costa Rica: Tres Ríos, Costa Rica: INCIENSA [homepage en Internet]; Instituto Costarricense de Investigación y Enseñanza de Nutrición y Salud, 2012 julio [citado 19 de Septiembre de 2016]. Disponible en: http://www.inciensa.sa.cr/

  10. El-Shabrawi MH, Atef Tolba O, El-Adly TZ. Efficacy and safety of cefpodoxine in the treatment of acute otitis media in children. Egyptian Pediatric Association Gazette. 2016;64:81-5.

  11. Leeberthal AS, Carrol AE, Chonmaetre T, Ganiats TG, Hoberman A, Jackson MA, et al. The diagnosis and management of acute otitis media. Pediatrics. 2013;131(3):e964-99.

  12. Taylor S, Marchesio P, Vergison A, Hausdorrf WP, Haggard M. Impact of pneumococcal conjugate vaccination on otitis media: a systematic review. Clin Infect Dis. 2012;54(12):1765-73.

  13. Ngo CC, Masso HM, Thornton RB, Cripps AW. Predominant bacteria detected from the middle ear fluid of children experiencing otitis media: A systematic review. PLoS ONE. 2016;11(3):e0150949.

  14. Reijtman V, Fossati S, Hernandez C, Sommerfieck P, Bernáldez P, Litterio M, et al. Serotype distribution of pneumococci isolated from pediatric patients with acute otitis media and invasive infection, and potential coverage of pneumococcal conjugate vaccines. Rev Argent Microbiol. 2013;45(1):27-33.

  15. Cabrera-Gaytan DA, Gabriel V, Ernesto K, Concepción G. Otitis media aguda. Rev Med Inst Mex Seguro Soc. 2014;52(2):150-5.

  16. Tasnee C, Rocio T, Kristopher J, Pedro AF, Janak AP, Michael JL, et al. Acute Otitis Media and other complications of viral Respiratory Infection. Pediatrics. 2016;137:2015-35553.

  17. Goldstein B, Giroir B, Randolph A, and members of the International Consensus Conference on Pediatric Sepsis. Internationals pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in paediatrics. Pediatrics Critical Care Medicine. Abril 2005;6(1):2-8.

  18. Dickinson Meneses FO. Aportes a la epidemiología de la meningitis bacteriana [tesis doctoral]. La Habana; 2011.

  19. Golden AR, Heather JA, Zhanel G. Invasive Streptococcus pneumoniae in Canada, 2011-2014: Characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33F. Vaccine. 2016;34:2527-30.

  20. OPS. Informe Regional de SIREVA II, 2012: datos por país y por grupos de edad sobre las características de los aislamientos de Streptococcus pneumoniae, Haemophilus Influenzae y Neisseria meningitidis en procesos invasores. Washington: OPS; 2013. p. 139-54.




2020     |     www.medigraphic.com